Defense awards $67M for airworthy defibrillators

The Department of Defense awarded contracts topping a combined $67 million to two companies for airworthy defibrillators under its war-stopper funds.

Zoll Medical will receive $39.8 million under a five-year contract. Zoll manufactures the Propaq MD, an airworthy defibrillator that allows for monitoring patients during long transports. The device has been cleared by the FDA and includes a night vision mode.

Philips Healthcare’s $27.4 million, five-year contract also is for airworthy defibrillators. Philips makes the HeartStart MRx Monitor/Defibrillator, which has been certified by the U.S. Army as airworthy and received a Safe-to-Fly certificate from the Air Force. It combines defibrillation and monitoring technology.

Zoll Medical in Chelmsford, Mass., and Philips Healthcare is in Andover, Mass.

 

Candace Stuart, Contributor

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Trimed Popup
Trimed Popup